IGBA - International Generic and Biosimilar medicines Association

IGBA - International Generic and Biosimilar medicines Association is dedicated to strengthening worldwide cooperation among associations that represent generic and biosimilar medicines manufacturers. IGBA plays a crucial role in fostering sustainable competition within the pharmaceutical industry, stimulating both competitiveness and innovation. This commitment ensures that millions of patients globally have access to high-quality, pro-competitive medicines.

Located at Rue de Cornavin 11, C/O DYN SA, Geneva, 1201, CH, IGBA is committed to advancing the interests of generic and biosimilar medicine manufacturers on a global scale. By promoting a competitive and innovative pharmaceutical sector, IGBA helps to ensure that patients worldwide benefit from access to affordable and effective treatments.

IGBA's efforts contribute significantly to the sustainability and growth of the pharmaceutical industry. The organization continuously works to enhance the availability of high-quality medicines, making a positive impact on healthcare systems worldwide. We invite the management of IGBA - International Generic and Biosimilar medicines Association to create a customized and exclusive company showcase and product listing on our platform to further highlight your contributions.